| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911135 | Lung Cancer | 2014 | 6 Pages |
Abstract
We conclude that Gal-1 expression may be a useful biomarker for better prediction of the clinical outcome and management of NSCLC patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
MarÃa José Carlini, Pablo Roitman, Myriam Nuñez, MarÃa Guadalupe Pallotta, Gastón Boggio, David Smith, Mariana Salatino, Elisa D. Bal de Kier Joffé, Gabriel A. Rabinovich, Lydia I. Puricelli,